Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Early Left Bundle Branch Pacing for Complete Left Bundle Branch Block and Left Ventricular Ejection Fraction of 36%-50%: The EARLY-RESYNC Randomized Trial.

Created on 16 Nov 2026

Authors

Haojie Zhu, Yao Wang, Kailun Zhu, Jiaxin Zeng, Chen He, Xiaofei Li, Jifang Ma, Haixia Fu, Zhimin Liu, Yan Yao, Jiangang Zou, Xiaofeng Hou, Xiaohan Fan, EARLY-RESYNC Investigators

Published in

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

To compare the effects of early resynchronization with left bundle branch pacing (early-LBBP) versus guideline-directed medical therapy (GDMT) alone on cardiac function in patients with complete left bundle branch block (CLBBB) and left ventricular ejection fraction (LVEF) of 36%-50%.
In this prospective, randomized, multicenter trial, 37 patients (mean age 60.5 ± 12.3 years, male 40.5%, LVEF 42.6% ± 6.0%) were assigned to early-LBBP plus GDMT (n=19) or GDMT alone (n=18). The primary endpoint was the between-group difference in the change of LVEF from baseline to 6 months. Secondary endpoints included changes in echocardiographic parameters and clinical outcomes. Analyses were performed according to the intention-to-treat principle. At 6-month follow-up, the adjusted mean improvement in LVEF was greater in the early-LBBP group than in the GDMT group (mean difference: 7.4%, 95% CI: 1.9 to 12.9%; P =0.013), with consistent findings in the per-protocol analysis. Early-LBBP was also associated with a greater reduction in LV end-systolic volume (-23.6mL; 95% CI: -42.3 to -4.8ml) and a higher rate of final LVEF ≥50% (78.9% vs. 38.9%) at 6 months compared with GDMT alone.
In patients with CLBBB and LVEF 36%-50%, LBBP combined with GDMT resulted in greater improvement in LVEF at 6 months than GDMT alone. Larger randomized trials are needed to establish its long-term clinical benefits and optimal timing.

PMID:
43036879
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement